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2ABSTRACT
We sought to examine the relationship globally between UV dose exposure and current eczema
prevalences.
ISAAC Phase Three provided data on eczema prevalence for 13-14 year-olds in 214 centres in 87
countries and for 6-7 year-olds in 132 centres in 57 countries. Linear and non-linear associations
between (natural log transformed) eczema prevalence and the mean, maximum, minimum,
standard deviation and range of monthly UV dose exposures were assessed using linear mixed-
effects regression models.
For the 13-14 year olds, the country-level eczema prevalence was positively and linearly
associated with country-level monthly mean (prevalence ratio: 1.31, 95% confidence interval:
[1.05, 1.63] per kJ/m2) and minimum (1.25 [1.06, 1.47] per kJ/m2) UV dose exposure. Linear and
non-linear associations were also observed for other metrics of UV. Results were similar in trend,
but non-significant, for the fewer centres with 6-7 year-olds (e.g. 1.24 [0.96, 1.59] per kJ/m2 for
country-level monthly mean UV). No consistent within-country associations were observed (e.g.
1.05 [0.89, 1.23] and 0.92 [0.71, 1.18] per kJ/m2 for center-level monthly mean UV, for the 13-14
and 6-7 year-olds, respectively).
These ecological results support a role for UV exposure in explaining some of the variation in
global childhood eczema prevalence.
3INTRODUCTION
Childhood eczema is a highly prevalent condition known to be strongly associated with genetic
risk factors, such as mutations in the filaggrin gene (Irvine et al. 2011). However, differences in
global prevalence (Williams et al. 2008), associations with family size and results from migrant
studies (Williams 1995) all suggest environmental factors are also likely to play a role.
Although the evidence of the effectiveness of short-term ultraviolet radiation treatment on
eczema (in adults) is increasing (Garritsen et al. 2014), little is known about the effects of long-
term exposure. Climatic and ultraviolet radiation (UV) long-term exposures have been associated
with eczema prevalence and severity of symptoms in studies in North America and Europe
(Kathuria and Silverberg 2016, Krämer et al. 2005, Sargen et al. 2014, Silverberg et al. 2013,
Suárez-Varela et al. 2008, Vocks et al. 2001). Overall, these studies suggest that climatic factors,
such as temperature and humidity, as well as UV exposure, may influence eczema prevalence and
symptoms, although the direction and consistency of the effects vary across studies. Indeed,
Langan and Irvine (2013) recently reviewed the existing conflicting evidence and called for
additional large studies to clarify the associations and elucidate potential mechanisms. In
particular, no study has yet included data from developing countries, where eczema prevalences
are increasing (Williams et al. 2008) and where UV exposures can be high. A better
understanding of the existing relationships between the environment and eczema development
and prevalence could lead to opportunities for early intervention and (possibly) climate-specific
treatment regimes (Langan and Irvine et al 2013).
A previous study using data from the International Study of Asthma and Allergies in Childhood
4(ISAAC) Phase One reported that childhood and adolescent eczema prevalence were positively
correlated with latitude and negatively correlated with annual outdoor temperature in Western
Europe. One explanation provided was a potential indirect effect due to changes in behaviour and
sun exposure, which would also be correlated with temperature and latitude (Weiland et al. 2004).
The current study extends this work by using the substantially larger ISAAC Phase Three data set
(Odhiambo et al. 2009) to examine associations between metrics of UV dose exposures and the
prevalence of current eczema among children and adolescents in a global context.
5RESULTS
For the 214 centres with 13-14 year-olds, the median centre-level eczema prevalence was 5.73
(range: 0.17-24.6) and varied by climate type (analysis of variance, P = 0.06; Table 1). The
median centre-level prevalence for the 132 centres with 6-7 year-olds was 6.99 (range: 0.95-
22.5). Centre-level prevalences between the age groups were highly correlated for the 129 centres
that had information for both age groups (Spearman correlation = 0.76). Centre-specific sample
sizes, eczema prevalences and monthly mean UV dose exposures are reported in Tables S1 and
S2 for the 13-14 year-olds and 6-7 year-olds, respectively.
Spearman correlations between the modeled variables and centre-level eczema prevalences for
the centres with 13-14 year-olds are provided in Table 2. Among the many correlations, centre-
level eczema prevalence was positively correlated with country-level gross national income
(GNI) and centre-level relative humidity, and negatively correlated with the centre-level standard
deviation and range of monthly UV levels. The different measures of UV exposures were inter-
correlated. These correlations were very similar for the centres with 6-7 year-olds (Table S3).
Between-country associations (comparing country-level information) are reported in Table 3
(both age groups) and the shape of these associations are depicted in Figure 1 and Figure S1 for
the 13-14 and 6-7 year-olds, respectively. For the centres with 13-14 year-olds, country-level
monthly mean, maximum and minimum UV levels were positively associated with country-level
current eczema prevalence (prevalence ratio: 1.31 [95% confidence interval: 1.05, 1.63], 1.25
[1.00, 1.57] and 1.25 [1.06, 1.47], respectively). When quadratic terms (exposure2) were
introduced into the models for maximum, standard deviation and range of monthly UV, as this
6represents a better model fit to the data, the quadratic terms were all statistically significant,
suggesting the existence of non-linear relationships. When replicated in the centres with 6-7 year-
olds, the effect estimates were similar in trend, but were attenuated and none were statistically
significant. The results from the models containing linear terms only are presented as prevalence
ratios in Table S4 (this type of presentation is inappropriate for models containing linear and
quadratic terms).
Two significant negative linear within-country associations (comparing centres within countries)
were observed for centres with 13-14 year-olds but these did not replicate in the centres with 6-7
year-olds (Table 3).
Stratification by whether or not eczema first occurred before or at/after the age of two years
suggest that the between-country associations (comparing country-level information) could be
driven by the later phenotype (Table 4). This analysis could only be conducted among centres
with 6-7 year-olds as this information was not collected from the 13-14 year-olds.
Although statistical significance was occasionally lost, the effect estimates were highly consistent
when the outcome was restricted to eczema symptoms which kept the participant awake one or
more nights per week (severe eczema, Table S5), despite a substantial reduction in centre-level
prevalences (median prevalence was 7.0% for current eczema and 0.8% when restricted to severe
symptoms).
The removal of centres with the lowest and highest centre-level eczema prevalences or centre-
7level UV exposures (up to 10% of the sample removed) did not alter the between-country
associations (comparing country-level information). Removal of the two countries with the
lowest and highest country-level UV exposure metrics (4 countries in total out of 87) also yielded
fairly consistent results, although the between-country associations for monthly mean and
minimum UV were attenuated and no longer significant. When 10% of the sample was removed
based on country-level UV exposure extremes, the between-country effect estimates were similar
in trend but nearly all were no longer significant.
Stratification by climate type suggested that the between-country associations (comparing
country-level information) were most apparent among areas with climates classified as warm
temperate and fully humid, although there may be an insufficient number of centres in the other
climate groups to detect associations (Table 5).
8DISCUSSION
Main Findings
In this worldwide ecological analysis, several between-country associations between metrics of
UV exposure and current eczema prevalence were observed among centres with 13-14 year-
oldsOur results suggest a positive linear association between country-level eczema prevalence
with country-level mean and minimum monthly UV dose levels (which were highly correlated, rs
= 0.98) and non-linear relationships between the country-level maximum, standard deviation and
range of monthly UV dose levels (the latter two of which were highly correlated, rs = 0.99). When
replicated in the centres with 6-7 year-olds, these associations were similar in trend but were not
statistically significant, most likely because of the fewer number of centres in this age-group.
Comparison with other Studies
Previous studies on this topic point to a complex relationship. The most recent efforts include a
longitudinal study in Germany in which some participants reported that their eczema symptoms
were worse in the summer, yet others reported worse symptoms in the winter (Krämer et al.
2005). This effect was thought to be at least partly driven by environmental allergen exposure and
sensitization. Two recent studies in the United States of America published a year apart came to
rather different conclusions. A large-scale ecological study reported reduced eczema prevalence
in areas with (among other things) high relative humidity, high UV index and high mean
temperature (Silverberg et al. 2013), whereas a prospective cohort study reported that warm,
humid and high sun exposure climates were associated with poorly controlled eczema (Sargen et
al. 2014). Furthermore, a recent large population-based ecological study in the United States of
America demonstrated the complexity that likely exists between coexisting climatic factors and
9pollutants. For example, this study reported that areas classified as hot, sunny, and with high
levels of ozone and particulate matter with an aerodynamic diameter of 10 μm or less had lower 
eczema prevalence (Kathuria and Silverberg 2016). The results of the current analysis add to this
complexity by suggesting the existence of both linear and non-linear associations (on a global
scale) with different metrics of UV dose exposure. The possibility that extremes of UV exposure
in either direction might increase the risk of eczema is not implausible and could help reconciliate
the current seemingly conflicting data from different regions and study designs. Our finding that
associations were strongest in countries classified as warm temperate and fully humid is also
interesting, but should be interpreted cautiously due to the smaller number of countries in the
other climate groups.
Possible Mechanisms
Several biological mechanisms by which UV exposure may affect eczema symptoms have been
proposed, including UV-epidermal interactions (Schwarz and Schwarz 2011), UV-induced DNA
methylation and gene-environment interactions. Indirect or interactive effects with other climatic
factor, such as humidity and temperature, are also probable (Langan and Irvine 2013). It is
unknown how these interactions may have resulted in the non-linear relationships observed for
certain metrics of UV dose exposure. Sensitivity analyses in which up to 10% of the sample were
removed did not largely change the non-linear associations, suggesting that these relationships
are not driven by a small subset of outlying centres. Although all models were adjusted for a
variety of important factors, these adjustments are unlikely to address all potential relevant
factors and interactions.
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We were unable to investigate whether differences in the distribution of important genetic risk
factors may be confounding our associations as it was not feasible to collect genetic data. It is
known that the prevalence and profiles of mutations in the FLG gene vary geographically and it
has been suggested that certain mutations may correlate with UV exposure (Cascella et al. 2015).
Further, areas of the skin more exposed to climatic and physical stressors have been shown to be
affected more often in FLG mutation carriers, suggesting that filaggrin-deficient individuals may
have a reduced ability to adapt to environmental exposures (Carson et al. 2012). Interestingly,
genetic risk factors appear to have the strongest influence on early-life eczema (by the first year
(Bønnelykke et al. 2010)), whereas the associations in our study were most consistent for eczema
with first onset at/after two years of age. One could thus speculate that any effect of UV exposure
would be more apparent (or easier to detect) after the influence of genetic risk factors has taken
place. The results of our age-stratified analyses should however be interpreted with caution given
that this analysis could only be conducted in centres with 6-7 year-olds.
Strengths and Limitations of Study
The between-country associations are based on the entire data set and thereby take advantage of
the large number and exposure contrasts of the participating countries. However, these
associations are more likely than the within-country associations to be influenced by unmeasured
factors that differ by country, and issues related to the translation of questionnaires (Ellwood et
al. 2009). We thus cannot confirm that the between-country associations are not driven by
residual confounding. We found no consistent within-country associations, possibly because of a
smaller exposure range and sample size as only countries with more than one centre could
contribute.
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Our definition of eczema was identical to the standardized and validated definition used to assess
worldwide differences and changes in eczema prevalences in the successive phases of ISAAC
(Williams et al. 2008), and has been shown to provide adequate prevalence estimates at the
population level (Flohr et al. 2009). It nevertheless remains possible that there may be variation
in the way the questionnaires were completed or administered, although all study centres
followed the same protocol. The fact that similar patterns with UV exposures were observed for
eczema symptoms classified as severe supports the existence of a harmonized approach as severe
symptoms are less likely to be deferentially reported than mild symptoms. Previous studies have
reported that eczema flares during particular times of the year and in response to weather effects
(Krämer et al. 2005; Langan et al. 2009), which could be associated with UV exposure levels. We
could not examine season-specific associations as the questionnaire asked for eczema prevalence
over a 12 month period. This gap should be addressed in future work.
The size and coverage of ISAAC, which includes regions rarely or never studied in this context,
makes this study unique in its ability to investigate global associations between ecologic metrics
of UV dose exposures and current eczema prevalence However, there remain areas of the world
which are poorly covered in this analysis, such as countries with colder climates. It should also be
noted that the participating centres were not randomly selected. Thus it is unknown whether the
results may be generalizable worldwide. Given these limitations, we recommend focusing on the
trends of the associations presented (Figure 1), which may indicate new directions for research,
and not on the exact values of the effect estimates reported.
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The UV exposure data was selected to overlap with the beginning of the health data collection
period for ISAAC Phase Three. Any temporal changes in UV exposures that occurred between
the time of birth of the participants and the time the health data were collected are expected to be
minimal compared to the differences in UV exposures between countries and centres. For the rest
of the adjustment covariates, we attempted to use data from the same period although not all data
sets overlap. Common to all ecological studies, we had no information on potentially relevant
individual-level factors, such as race or skin type, and were thus unable to explore effect
modification by behavioral factors that could influence an individual's exposure to UV, such as
time spent outdoors and wearing sun-protective clothing. Nonetheless, the collection of data from
both 13-14 year-olds and 6-7 year-olds allowed nearly all analyses to be replicated in an
independent population. We focused on associations that were statistically significant in the
larger group of centres (the 13-14 year olds) and that replicated at least in trend in the fewer
centres with 6-7 year-olds. This was the case for all the between-country associations but no
within-country associations.
In conclusion, we provide further support for a role of environmental factors on eczema. Several
between-country associations between metrics of UV dose exposure and current eczema
prevalence were observed, with some indication that non-linear associations may exist on a
global scale. Given the ecological design of this study and the possibility of residual
confounding, these results should be interpreted with caution until replicated using individual
exposure data in a prospective study design.
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METHODS
Study Population
The rationale and methods for ISAAC Phase Three have been published (Ellwood et al. 2005).
The current analysis includes information on 214 centres in 87 countries for the 13-14 year-olds
and 132 centres in 57 countries for the 6-7 year-olds for which the required health and
environmental data were available (flow chart in Figure S2). Ethical approval from local ethics
committees or boards were obtained for all collaborating centres. Parental completion of the
questionnaire for the 6-7 year-olds implied consent. For the older age group, passive consent for
the teenager to complete their own questionnaire at school was mostly used.
Health Outcomes
Using standardized self-completed (for adolescents 13-14 years-old) or parent-completed (for
children 6-7 years-old) ISAAC questionnaires, individuals were asked to indicate if they (or their
child) had an itchy rash at any time in the last 12 months and whether this itchy rash had affected
any of the following places: the folds of the elbows, behind the knees, in front of the ankles,
under the buttocks, or around the neck, ears or eyes? A positive answer to both questions was
used to define current eczema and centre prevalences of this outcome were calculated (Odhiambo
et al. 2009). Subsequent questions asked about the age of first onset of the itchy rash symptoms
and how often these symptoms kept the participant awake at night. Using this information,
centre-level prevalences of eczema with first onset before versus at/after age two years, as well as
severe eczema (kept the participant awake one or more nights per week) were calculated. The
exact wording of the questions are provided in the Supplementary Material.
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Methods Relating to Environmental Assessments
Monthly data on UV radiation dose in the erythema range (280-400nm, believed to be important
for the effects on human skin (McKinlay and Diffey 1987)) were obtained from the Tropospheric
Emission Monitoring Internet Service for the year 2001, at a resolution of 0.5o x 0.5o (European
Space Agency). UV dose data were used, instead of UV index data, as the former is a measure of
the total amount of UV radiation absorbed by the human skin during the day (kJ/m2) after
considering cloud cover.
Population density data for 2000 (at a spatial resolution of 2.5 arc minutes) were obtained from
the Socioeconomic Data and Applications centre (Socioeconomic Data and Applications Center
2004). Data on GNI per capita in 2001 were obtained from the World Bank (Atlas Method 2003;
(World Bank 2012)). For the seven countries for which this information was missing, GNI data
were imputed using information from the Central Intelligence Agency World Fact Book (2003)
(Central Intelligence Agency 2007).
Data on monthly mean daily temperature and precipitation averaged for 1991 - 2000 for 0.5o x
0.5o grids were obtained from the Intergovernmental Panel on Climate Change Data Distribution
centre (Mitchell 2004; Mitchell and Jones 2005). These data were used to classify centres into
five climate types according to the Köppen climate classification system ( (Kottek et al. 2006)).
Monthly mean relative humidity data, averaged for 1961-1990 and available at a 10' resolution,
was also obtained (New et al. 2002).
The assignment of environmental variables to the centres has been described (Anderson et al.
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2012; Fuertes et al. 2014). Coordinates for the study population were assigned to a 0.1o x 0.1o
square and compared with the eight surrounding 0.1o x 0.1o squares. The square with the highest
population density was considered the centre grid and used for mapping. UV dose and climate
data were mapped to this single coordinate. For population density, the mean values of the centre
grid and eight surrounding grids (each sized 0.07o x 0.07o) were used. For UV dose, climate and
population density variables, which were available at the centre-level, country-level means were
calculated (Begg and Parides 2003), which may not reflect the true mean of a country.
Analytic Strategy
Correlations between centre-level variables were assessed using Spearman correlation
coefficients. Eczema prevalences were (natural) log-transformed before modeling. Linear
regression mixed models were used to assess associations between the mean, maximum,
minimum, standard deviation and range of monthly UV dose exposures and current eczema
prevalence (lme4 package (Bates et al. 2014) in the statistical program R, version 3.3.0 (R Core
Team 2012), assuming a symmetric variance-covariance matrix). Effect plots (from the effects
package (Fox et al. 2016)) were created to graphically display the terms of the regression models.
Given this study’s ecological design, the unit of analysis was “country” for the between-country
associations in which country-level information was compared, and “center” for the within-
country associations in which center-level information within countries was compared.
Initially, models containing only a linear term for each UV exposure variable were calculated and
are presented. High-order relationships were subsequently tested by including quadratic terms
(e.g. UV2). Evidence of non-linearity was observed for the maximum, standard deviation and
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range of monthly UV dose exposures for the between-country associations in the 13-14 year-old
age group. Thus, for these exposures only, models containing linear and quadratic terms (which
better fit the data) are also presented.
Models were adjusted for potential confounding factors including GNI per capita, population
density, climate type and monthly mean temperature and relative humidity. All models included
country as a random intercept and fixed effects for both the centre- and country-level
representation of each variable, except for GNI per capita, which was available only at the
country-level.
The regression coefficients (betas) and their corresponding 95% confidence intervals, calculated
as 1.96*(standard error) assuming a normal distribution, are presented for the linear and quadratic
terms per 1-unit increase in country-level exposure for the between-country associations and per
1-unit increase in centre-level exposure for the within-country associations. For the models
containing only linear UV terms, the beta estimates can be interpreted as prevalence ratios after
natural exponentiation, per increase in UV exposure. For the models containing linear and
quadratic terms, it is not possible to summarize the results using a single number that reflects
additive or relative changes (Barrera-Gómez and Basagaña 2015). Thus, in all Tables, the beta
estimates are not back-transformed from the (natural) logarithmic scale so that the models
containing only linear UV terms can be compared to those containing linear and quadratic UV
terms.
Sensitivity analyses
To assess the impact of outliers, separate analyses were conducted in which 1) the five centres
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with the lowest and highest centre-level eczema prevalence (~5% of sample) were removed, 2)
the five centres with the lowest and highest centre-level UV exposure metric were removed (~5%
sample), and 3) the two countries with the lowest and highest country-level UV exposure metric
were removed (~5% of the 87 country-level UV exposures). These analyses were replicated with
~10% of the sample removed instead.
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Table 1: Distribution of current centre-level eczema symptom prevalence and centre-level UV dose exposure variables overall, and by
climate type, for centres with 13-14 year-olds (N=214)
Overall
(N=214)
Snow/polar
(N=12)
Arid
(N=24)
Equatorial
(N=61)
Warm temperate
with dry winter
(N=20)
Warm temperate
fully humid
(N=97)
Median IQR Median IQR Median IQR Median IQR Median IQR Median IQR
Eczema symptoms 5.7 5.5 3.8 4.9 4.6 4.7 6.9 6.5 4.9 4.6 7.0 6.3
UV monthly mean 3.3 2.3 2.0 0.8 3.1 1.2 4.5 0.3 1.7 0.6 2.6 1.7
UV monthly maximum 5.2 1.4 4.0 1.1 5.4 1.0 5.5 0.3 3.5 0.8 4.9 1.7
UV monthly minimum 1.1 2.6 0.4 0.4 0.9 1.0 3.4 0.7 0.2 0.2 0.7 1.3
UV monthly SD 1.3 0.6 1.3 0.3 1.5 0.4 0.7 0.3 1.3 0.2 1.4 0.4
UV monthly range 3.3 1.5 3.6 0.8 4.2 1.0 2.2 0.8 3.3 0.5 3.7 1.2
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Table 2: Spearman correlations between modeled centre-level variables for the centres with 13- to 14-year olds (N=214)
Variable Period Median
(IQR)
Eczema
sympto
ms
GNI per
capita
Populati
on
density
Temper
ature
Relative
humidit
y
Mean Max Min SD Range
Eczema symptoms 2000-2003 5.7 (5.5) 1 0.18** -0.06 0.04 0.33*** 0.10 0.06 0.12 -0.17* -0.17*
GNI per capita per 1000 2001 3.3 (10.6) 1 -0.14* -0.39*** 0.36*** -0.48*** -0.44*** -0.48*** 0.14* 0.13
Population density per 1000 2000 0.9 (2.4) 1 0.27*** -0.02 0.24** 0.15* 0.27*** -0.23*** -0.22**
Monthly mean temperature (oC) 1991-2000 18.0 (12.7) 1 -0.02 0.78*** 0.55*** 0.84*** -0.46*** -0.45***
Monthly mean relative humidity (%) 1961-1990 73.9 (12.7) -0.08 -0.23*** -0.03 -0.42*** -0.43***
UV monthly mean 2001 3.3 (2.3) 1 0.84*** 0.98*** -0.46*** -0.44***
UV monthly maximum 2001 5.2 (1.4) 1 0.79*** -0.01 0.01
UV monthly minimum 2001 1.1 (2.6) 1 -0.52*** -0.51***
UV monthly standard deviation 2001 1.3 (0.6) 1 0.99***
UV monthly range 2001 3.3 (1.5) 1
*<0.05; **<0.01; ***<0.001
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Table 3: Between- and within-country associations for current eczema symptom prevalence and
UV exposures for the centres with 13-14 year olds and 6-7 year olds. Beta estimates (not back-
transformed from the natural logarithmic scale) and their corresponding 95% confidence intervals
are presented1
UV exposure 13-14 yr olds 6-7 yr olds
Linear term Quadratic term Linear term Quadratic term
Between-country associations (comparing country-level information)
N = 214 centres in 87 countries N = 132 centres in 57 countries
Mean 0.27 [0.05, 0.49] - 0.21 [-0.04, 0.47] -
Max2 0.22 [0.00, 0.45] - 0.22 [-0.02, 0.46] -
0.31 [0.08, 0.53] 0.20 [0.05, 0.34] 0.23 [-0.02, 0.48] 0.11 [-0.04, 0.27]
Min2 0.22 [0.06, 0.39] - 0.14 [-0.07, 0.34] -
SD2 -0.34 [-0.78, 0.09] - -0.02 [-0.63, 0.59] -
-0.23 [-0.66, 0.20] 1.15 [0.28, 2.02] 0.00 [-0.62, 0.62] 0.21 [-0.75, 1.18]
Range2 -0.13 [-0.30, 0.05] - 0.02 [-0.21, 0.26] -
-0.10 [-0.27, 0.06] 0.19 [0.06, 0.33] 0.02 [-0.22, 0.25] 0.07 [-0.09, 0.22]
Within-country associations (comparing centres within countries)
N = 161 centres in 34 countries N = 96 centres in 21 countries
Mean 0.04 [-0.12, 0.20] - -0.08 [-0.34, 0.17] -
Max -0.13 [-0.31, 0.05] - -0.08 [-0.35, 0.19] -
Min 0.13 [-0.01, 0.28] - -0.07 [-0.27, 0.12] -
SD -0.74 [-1.16, -0.32] - 0.19 [-0.32, 0.70] -
Range -0.31 [-0.47, -0.14] - 0.03 [-0.17, 0.24] -
1Adjusted for centre mean exposure of interest (for between-country associations) or country mean exposure of
interest (for within-country associations), as well as the centre and country mean population density, mean monthly
temperature and mean monthly relative humidity, as well as country gross national per capita income and climate
type. Estimates from the models containing only linear terms can be interpreted as prevalence ratios after natural
exponentiation.
2 Results from two models are presented: one including only a linear term for the UV exposure and one including a
linear and quadratic term for the UV exposure. The significant positive quadratic terms observed for the maximum,
standard deviation and range of monthly UV measurements among the 13-14 year-olds suggest the existence of a
non-linear (convex) association with eczema prevalence.
Bold: p-value < 0.05
26
Table 4: Between- and within-country associations for current eczema symptom prevalence and
UV exposures for the centres with 6-7 year olds, stratified by whether eczema onset was before
or after age two years. Beta estimates (not back-transformed from the natural logarithmic scale)
and their corresponding 95% confidence intervals are presented1
UV exposure Eczema onset before age two years Eczema onset at/after age two years
Linear term Quadratic term Linear term Quadratic term
Between-country associations (comparing country-level information)
Mean 0.05 [-0.31, 0.41] - 0.31 [0.05, 0.57] -
Max2 0.12 [-0.22, 0.47] - 0.28 [0.02, 0.53] -
0.11 [-0.24, 0.46] 0.03 [-0.20, 0.25] 0.28 [0.02, 0.54] 0.12 [-0.04, 0.28]
Min -0.01 [-0.30, 0.28] - 0.20 [-0.03, 0.42] -
SD2 0.26 [-0.59, 1.10] - -0.04 [-0.69, 0.62] -
0.23 [-0.61, 1.08] -0.87 [-2.18, 0.43] -0.03 [-0.69, 0.62] 0.62 [-0.37, 1.61]
Range2 0.13 [-0.20, 0.46] - 0.00 [-0.25, 0.26] -
0.14 [-0.18, 0.47] -0.11 [-0.32, 0.10] -0.02 [-0.27, 0.23] 0.12 [-0.03, 0.28]
Within-country associations (comparing centres within countries)
Mean 0.08 [-0.27, 0.43] - -0.24 [-0.58, 0.11] -
Max 0.14 [-0.24, 0.51] - -0.20 [-0.57, 0.17] -
Min 0.04 [-0.24, 0.32] - -0.21 [-0.49, 0.06] -
SD 0.12 [-0.60, 0.85] - 0.43 [-0.29, 1.15] -
Range 0.04 [-0.26, 0.34] - 0.11 [-0.19, 0.41] -
1Adjusted for centre mean exposure of interest (for between-country associations) or country mean exposure of
interest (for within-country associations), as well as the centre and country mean population density, mean monthly
temperature and mean monthly relative humidity, as well as country gross national per capita income and climate
type. Estimates from the models containing only linear terms can be interpreted as prevalence ratios after natural
exponentiation.
2 Results from two models are presented: one including only a linear term for the UV exposure and one including a
linear and quadratic term for the UV exposure.
Bold: p-value < 0.05
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Table 5: Between-country associations (comparing country-level information) for current eczema symptom prevalence and UV exposures
for the centres with 13-14 year-olds, stratified by climate type. Beta estimates (not back-transformed from the natural logarithmic scale) and
their corresponding 95% confidence intervals are presented1
UV
exposure
Arid
(N=24 centres in 18 countries)
Equatorial
(N=61 centres in 31 countries)
Warm temperate with dry winter
(N=20 centres in 13 countries)
Warm temperate fully humid
(N=97 centres in 139 countries)
Linear term Quadratic term Linear term Quadratic term Linear term Quadratic term Linear term Quadratic term
Mean 0.12
[-0.54, 0.79]
- -0.11
[-0.88, 0.67]
- -0.54
[-2.92, 1.85]
- 0.45
[0.21, 0.69]
-
Max2 0.67
[0.04, 1.30]
- 0.05
[-1.05, 1.15]
- -0.72
[-1.87, 0.43]
- 0.51
[0.22, 0.79]
-
0.77
[-0.39, 1.94]
0.03
[-1.43, 1.49]
-2.86
[-6.68, 0.96]
2.23
[-0.57, 5.03]
-1.94
[-4.93, 1.05]
-0.60
[-2.02, 0.83]
0.52
[0.26, 0.79]
0.22
[0.05, 0.38]
Min -0.07
[-0.57, 0.42]
- 0.04
[-0.36, 0.44]
- -0.17
[-6.15, 5.80]
- 0.29
[0.10, 0.47]
-
SD2 0.63
[-0.71 1.96]
- -0.04
[-1.03, 0.94]
- -3.29
[-8.11, 1.54]
- -0.37
[-0.99, 0.26]
-
0.21
[-1.53 1.95]
1.48
[-2.12, 5.08]
0.83
[-1.03, 2.68]
1.47
[-1.19, 4.14]
-0.40
[-8.73, 7.92]
-7.36
[-23.92, 9.21]
-0.37
[-0.93, 0.19]
2.40
[0.99, 3.82]
Range2 0.30
[-0.20, 0.79]
- -0.01
[-0.43, 0.40]
- -1.02
[-2.32, 0.28]
- -0.13
[-0.37, 0.12]
-
0.12
[-0.55, 0.78]
0.27
[-0.34, 0.87]
0.22
[-0.52, 0.97]
0.16
[-0.25, 0.56]
-0.48
[-2.82, 1.86]
-0.83
[-3.07, 1.42]
-0.19
[-0.41, 0.02]
0.40
[0.18, 0.62]
1Adjusted for centre mean exposure of interest, centre and country mean population density, mean monthly temperature and mean monthly relative humidity, as well as
country gross national per capita income. Results for snow/polar climates not presented due to an insufficient sample size (12 centres in 8 countries). Estimates from the
models containing only linear terms can be interpreted as prevalence ratios after natural exponentiation.
2 Results from two models are presented: one including only a linear term for the UV exposure and one including a linear and quadratic term for the UV exposure. The
significant positive quadratic terms observed for the maximum, standard deviation and range of monthly UV measurements suggest the existence of a non-linear
(convex) association with eczema prevalence.
Bold: p-value < 0.05
28
FIGURE LEGENDS
Figure 1: Effect plots for the between-country associations (comparing country-level
information) for current eczema symptom prevalence and UV exposures for the centres
with 13-14 year-olds. The linear effects are presented in the left column and the quadratic effects
are presented in the right column. The corresponding 95% confidence intervals are shown in grey.
